Artikel

Intellectual Property, Innovation and Access to Health Products for COVID-19 : A Review of Measures Taken by Different Countries

---

The rising incidence of COVID-19 will require all countries, particularly developing and least developed countries, to be able to procure and manufacture the products required for the diagnosis, prevention and treatment of COVID-19. Intellectual property (IP) rights over such products can constrain the ability of countries to rapidly procure and produce and supply the products required at a mass scale. This Policy Brief describes the measures and actions taken by different countries to address potential IP barriers to access to the products required for COVID-19. A number of countries, both developed and developing, have adopted measures to enable governments to take action to overcome IP barriers in case they constrain acces to the products required for COVID-19. In addition to these measures, the World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) also allows considerable flexibility to adopt a number of other possible measures which can be considered by developing countries where necessary.

---

Ketersediaan

08004

346.048 NIR i

Perpustakaan DJKI Tangerang

Tersedia

Informasi Detail

Judul Seri

POLICY BRIEF

No. Panggil

346.048 NIR i

Penerbit

Geneva : South Centre., 2020

Deskripsi Fisik

6 hlm

Bahasa

English

ISBN/ISSN

-

Klasifikasi

346.048

Tipe Isi

text

Tipe Media

other

Tipe Pembawa

-

Edisi

No. 80 June 2020

Subjek

Intellectual property
Innovation
Health Products for COVID-19

Info Detail Spesifik

Nirmalya Syam is Senior Programme Officer of the Health, Intellectual Property and Biodiversity (HIPB) Programme of the South Centre

Pernyataan Tanggungjawab

-

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar